Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia

Luciana Teofili, Maurizio Martini, Luigi Maria Larocca, Tonia Cenci, Francesco Guidi, Robin Foa, Fiorina Giona, Lorenza Torti, Giovanna Palumbo, Angela Amendola

Risultato della ricerca: Contributo in rivistaArticolo in rivista

82 Citazioni (Scopus)


Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.
Lingua originaleEnglish
pagine (da-a)1048-1053
Numero di pagine6
RivistaJournal of clinical oncology : official journal of the American Society of Clinical Oncology
Stato di pubblicazionePubblicato - 2007


  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biological Markers
  • Child
  • Cohort Studies
  • Erythroid Precursor Cells
  • Female
  • Follow-Up Studies
  • GPI-Linked Proteins
  • Humans
  • Incidence
  • Isoantigens
  • Janus Kinase 2
  • Male
  • Membrane Glycoproteins
  • Middle Aged
  • Mutation
  • Myeloproliferative Disorders
  • Pedigree
  • Polycythemia Vera
  • RNA, Messenger
  • Receptors, Androgen
  • Receptors, Cell Surface
  • Receptors, Erythropoietin
  • Receptors, Thrombopoietin
  • Rome
  • Thrombocythemia, Essential
  • Thrombopoietin
  • Thrombosis
  • Time Factors


Entra nei temi di ricerca di 'Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia'. Insieme formano una fingerprint unica.

Cita questo